However, this increase in BUN is also affected by other factors: the concomitant loss of HS at least in part explains the increase in BUN and fully explains the CLP-induced decrease in glomerular filtration rate (GFR) (98)
Preclinical Evidence for Equipotency Across Vast Dose Ranges Multiple peer-reviewed animal studies across a variety of tissue types (tendon, ligament, gut, brain) have revealed that BPC-157 exhibits a phenomenon known as dose-equipotency [4, 5]
Protocol integration: Continue standard pressure-lowering drops as prescribed
Our products are manufactured in Nevada in a state-of-the-art, FDA-registered facility that meets or exceeds current Good Manufacturing Practices (cGMP)
Researchers hypothesize that this peptide may influence pathways related to cellular signaling, vascular activity, and structural organization within experimental systems
Genovese F, Manresa AA, Leeming DJ, Karsdal MA, Boor P